EU-regulated cannabis producer with vertically integrated supply chain
Curaleaf International operates a vertically integrated cannabis business spanning cultivation, extraction, processing, and retail across Europe, Canada, and Australasia. The hiring mix—dominated by healthcare and clinical roles with small engineering and data teams—reflects a regulated, operations-heavy business model; pain-point clustering around compliance, equipment reliability, and clinical team expansion signals scaling strain in a high-scrutiny environment where operational missteps carry legal and safety consequences.
Curaleaf International is a public-company cannabis producer and distributor operating across the EU, Canada, and Australasia. The business is structured vertically: cultivation and EU-GMP processing facilities in Portugal; processing, QA, and research in Spain; clinics and pharmacies in the UK and Poland; and a wholesaler operation in Germany. The product line spans medical cannabis through to consumer offerings. Supply-chain footprint and EU-GMP certifications position the company as a regulated pharmaceutical-grade producer rather than a lifestyle brand, with operational scale reaching 5,001–10,000 employees.
Vertically integrated across cultivation (Portugal), EU-GMP processing (Spain, Portugal), clinics and pharmacies (UK, Poland), and wholesale distribution (Germany, Canada). The network spans Europe, Canada, and Australasia.
Core stack: SAP, NetSuite, Microsoft 365, Zendesk, Business Central. Also uses AutoCAD, Excel, Adobe. No active replacements or new adopter signals in current data.
Other companies in the same industry, closest in size